Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.

Tohen M, Chengappa KN, Suppes T, Baker RW, Zarate CA, Bowden CL, Sachs GS, Kupfer DJ, Ghaemi SN, Feldman PD, Risser RC, Evans AR, Calabrese JR.

Br J Psychiatry. 2004 Apr;184:337-45.

2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.

[No authors listed]

Prescrire Int. 2005 Aug;14(78):140-2.

PMID:
16106596
4.

Polytherapy in bipolar disorder.

Lin D, Mok H, Yatham LN.

CNS Drugs. 2006;20(1):29-42. Review.

PMID:
16396522
5.

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

Tohen M, Chengappa KN, Suppes T, Zarate CA Jr, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2002 Jan;59(1):62-9.

PMID:
11779284
6.

Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.

Maina G, Albert U, Salvi V, Mancini M, Bogetto F.

J Affect Disord. 2007 Apr;99(1-3):247-51. Epub 2006 Oct 23.

PMID:
17056122
7.

Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania.

Baker RW, Brown E, Akiskal HS, Calabrese JR, Ketter TA, Schuh LM, Trzepacz PT, Watkin JG, Tohen M.

Br J Psychiatry. 2004 Dec;185:472-8.

8.

Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.

Sussman N, Mullen J, Paulsson B, Vågerö M.

J Affect Disord. 2007;100 Suppl 1:S55-63. Epub 2007 Mar 26.

PMID:
17383736
9.

Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.

Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, Tohen M.

J Clin Psychiatry. 2006 Jan;67(1):95-101.

PMID:
16426094
10.

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.

Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.

Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.

11.

A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.

Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R.

Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. Review.

12.

Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.

Katagiri H, Takita Y, Tohen M, Higuchi T, Kanba S, Takahashi M.

Curr Med Res Opin. 2012 May;28(5):701-13. doi: 10.1185/03007995.2012.666961. Epub 2012 Apr 10.

PMID:
22356118
13.

Olanzapine in long-term treatment for bipolar disorder.

Cipriani A, Rendell JM, Geddes J.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004367. doi: 10.1002/14651858.CD004367.pub2. Review.

PMID:
19160237
14.

Predictors of relapse or recurrence in bipolar I disorder.

Degenhardt EK, Gatz JL, Jacob J, Tohen M.

J Affect Disord. 2012 Feb;136(3):733-9. doi: 10.1016/j.jad.2011.09.051. Epub 2011 Oct 28.

PMID:
22036802
15.

Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder.

Tohen M, Sutton VK, Calabrese JR, Sachs GS, Bowden CL.

J Affect Disord. 2009 Jul;116(1-2):43-50. doi: 10.1016/j.jad.2008.11.003. Epub 2008 Dec 2.

PMID:
19054570
16.

The antidepressant effects of risperidone and olanzapine in bipolar disorder.

McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH.

Can J Clin Pharmacol. 2004 Fall;11(2):e218-26. Epub 2004 Oct 4.

17.

Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.

Houston JP, Ahl J, Meyers AL, Kaiser CJ, Tohen M, Baldessarini RJ.

J Clin Psychiatry. 2006 Aug;67(8):1246-52.

PMID:
16965203
18.
19.

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial.

Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A.

Br J Psychiatry. 2003 Feb;182:141-7. Erratum in: Br J Psychiatry. 2003 Apr;182:369.

20.

Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium.

Houston JP, Lipkovich IA, Ahl J, Rotelli MD, Baker RW, Bowden CL.

J Psychiatr Res. 2007 Oct;41(7):616-21. Epub 2005 Oct 17.

PMID:
16236320
Items per page

Supplemental Content

Write to the Help Desk